Europe Contract Research Organization (CRO) Market

The Europe contract research organization (CRO) market is expected to reach US$ 22,157.62 Mn in 2025 from US$ 12,476.8 Mn in 2017. The market is estimated to grow with a CAGR of 7.7% from 2018-2025.

The growth of the Contract Research Organization (CRO) market is driven by factors such as a rise in the number of clinical trials. However, the market is likely to get impacted due to the dearth of skilled professionals and regional competition in the CRO services market in the region.

Pharmaceutical and biotech companies are focusing on research and development (R&D) to come up with new molecules for various therapeutic applications with the highest medical and commercial potential. The companies invest majorly in the R&Ds to deliver high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years according to a report published by European Federation of Pharmaceutical Industries and Associations (EFPIA) in 2018, the pharmaceutical R&D expenditure in Germany has increased from US$ 7,100.6 million (6,216 € million) in 2015 to US$ 7,113.2 million in 2015 (6,227€ million). Research and development expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as demonstrating product efficacy and regulatory compliance before launch. Therefore, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) in order to save the cost and time which is expected to drive the growth of the market.

The UK is expected to lead the market in the region owing to increasing expenditure on research and development expenditures in the country. The confrontation between biotechnology and pharmaceutical companies to lower the drug development costs is expected to propel the CROs market in Europe. Moreover, the presence of top revenue-generating pharmaceutical companies that can invest a significant amount in R&D is also expected to boost the growth of CROs in the region. Therefore, considering the factors mentioned above, the growth of the market in the country is likely to contribute the largest share in the European region during the forecast period.

France Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)

 

Get more information on this report Request Free Sample PDF

Europe Contract Research Organization (CRO) Strategic Insights

Strategic insights for the Europe Contract Research Organization (CRO) provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Get more information on this report Request Free Sample PDF

Europe Contract Research Organization (CRO) Report Scope

Report Attribute	Details
Market size in 2017	US$ 12,476.8 Million
Market Size by 2025	US$ 22,157.62 Million
Global CAGR (2018 - 2025)	7.7%
Historical Data	2015-2016
Forecast period	2018-2025
Segments Covered	By Type Early Phase Development Services Clinical Research Services Laboratory Services Post-Approval Services By End User Pharmaceutical & Biotechnology Companies and Medical Device Companies
Regions and Countries Covered	Europe UK Germany France Russia Italy Rest of Europe
Market leaders and key company profiles	IQVIA Laboratory Corporation of America Holdings PAREXEL International Corporation ICON plc Syneos Health PRA Health Sciences Charles River Pharmaceutical Product Development, LLC WuXi AppTec Medpace

Get more information on this report Request Free Sample PDF

Europe Contract Research Organization (CRO) Regional Insights

The geographic scope of the Europe Contract Research Organization (CRO) refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Get more information on this report Request Free Sample PDF

EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) – MARKET SEGMENTATION

EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) – By Type

• Clinical Research Services
• Early Phase Development Services
• Laboratory Services
• Post-Approval Services

EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) – By End User

• Pharmaceutical & Biotechnology Companies
• Medical Device Companies

EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) – By Geography

• Europe

• Germany
• UK
• France

Company Profiles

• IQVIA
• Laboratory Corporation of America Holdings
• PAREXEL International Corporation
• ICON plc
• Syneos Health
• PRA Health Sciences
• Charles River
• Pharmaceutical Product Development, LLC
• WuXi AppTec
• Medpace